Stockscreener 앱 받기
4.85
25.65%
0.99
시간 외 거래:
4.78
-0.07
-1.44%
전일 마감가:
$3.86
열려 있는:
$3.78
하루 거래량:
16.75M
Relative Volume:
1.79
시가총액:
$1.45B
수익:
$6.23M
순이익/손실:
$-95.90M
주가수익비율:
-12.44
EPS:
-0.39
순현금흐름:
$-68.47M
1주 성능:
+24.36%
1개월 성능:
+51.56%
6개월 성능:
+278.91%
1년 성능:
+449.33%
1일 변동 폭
$3.74
$5.19
1주일 범위
$3.74
$5.19
52주 변동 폭
$0.6513
$5.225
Precigen Inc Stock (PGEN) Company Profile
명칭
Precigen Inc
전화
301-556-9900
주소
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
PGEN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PGEN
Precigen Inc
|
4.85 | 1.36B | 6.23M | -95.90M | -68.47M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.15 | 110.25B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
693.50 | 73.04B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.16 | 59.98B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
907.98 | 54.90B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.22 | 40.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-15 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-03-22 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-05-23 | 개시 | JP Morgan | Neutral |
| 2022-11-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-02-25 | 개시 | Stifel | Buy |
| 2021-02-22 | 개시 | Wells Fargo | Overweight |
| 2021-02-18 | 개시 | B. Riley Securities | Buy |
| 2020-05-08 | 개시 | H.C. Wainwright | Buy |
모두보기
Precigen Inc 주식(PGEN)의 최신 뉴스
What’s the recovery path for long term holders of Precigen Inc.Earnings Risk Report & Community Driven Trade Alerts - newser.com
Vaxart (VXRT) and Precigen (PGEN) Shares Surge on Strong Q3 Earnings - GuruFocus
Vaxart, Precigen gain after Q3 2025 results (VXRT) - Seeking Alpha
Will Precigen Inc. stock benefit from AI adoptionJuly 2025 Market Mood & Weekly Setup with High ROI Potential - newser.com
Commit To Buy Precigen At $3.50, Earn 27.1% Using Options - Nasdaq
How Precigen Inc. stock performs in interest rate cyclesJuly 2025 Update & Growth Oriented Trading Recommendations - Fundação Cultural do Pará
Is Precigen Inc. stock in correction or buying zoneTrade Risk Summary & Safe Entry Momentum Tips - newser.com
Precigen, Inc. (NASDAQ:PGEN) Q3 2025 Earnings Call Transcript - Insider Monkey
Precigen (PGEN): HC Wainwright & Co. Adjusts Price Target to $9. - GuruFocus
Can technical indicators confirm Precigen Inc.’s reversalGap Down & Stock Timing and Entry Methods - newser.com
Will Precigen Inc. stock gain from lower inflationJuly 2025 Review & Consistent Profit Focused Trading Strategies - Fundação Cultural do Pará
Precigen stock holds steady as Citizens reiterates $8 price target By Investing.com - Investing.com UK
Precigen stock holds steady as Citizens reiterates $8 price target - Investing.com
Precigen Reports Q3 2025 Results and PAPZIMEOS Launch - TipRanks
Decoding Precigen Inc (PGEN): A Strategic SWOT Insight - GuruFocus
Precigen Inc (PGEN) Q3 2025 Earnings Call Highlights: FDA Approval and U.S. ... - Yahoo Finance
Transcript : Precigen, Inc., Q3 2025 Earnings Call, Nov 13, 2025 - MarketScreener
Using R and stats models for Precigen Inc. forecastingEarnings Trend Report & Weekly Breakout Watchlists - newser.com
Precigen’s Big Bet On PAPZIMEOS Leads To Bigger Losses - Finimize
Precigen Bets On New FDA-Approved Drug Despite Bigger Q3 Loss - Finimize
Earnings call transcript: Precigen Q3 2025 sees revenue beat but EPS miss - Investing.com India
Precigen (PGEN) Q3 2025 Earnings Call Transcript - The Globe and Mail
FDA Approval Boosts PGEN's PAPZIMEOS Rollout for RRP Treatment - GuruFocus
Precigen earnings missed by $0.97, revenue topped estimates - Investing.com Canada
Precigen Q3 Loss Widens, Revenue Rises - MarketScreener
Biopharmaceutical company Precigen Q3 net loss widens - MarketScreener
Earnings Flash (PGEN) Precigen Posts Q3 Loss Per Share $1.06, vs. FactSet Est of $0.09 Loss, If Comparable - MarketScreener
Using data tools to time your Precigen Inc. exitAnalyst Upgrade & Weekly Return Optimization Plans - newser.com
Precigen Reports Third Quarter 2025 Financial Results and Business Updates - PR Newswire
Published on: 2025-11-13 12:18:49 - newser.com
Chart based exit strategy for Precigen Inc.Quarterly Market Summary & Daily Oversold Stock Bounce Ideas - newser.com
Why Precigen Inc. stock appeals to dividend seekersBull Run & Daily Risk Controlled Trade Plans - newser.com
Intraday pattern recognizer results for Precigen Inc.July 2025 Action & Risk Controlled Stock Alerts - newser.com
Strategies to average down on Precigen Inc.Market Sentiment Review & Real-Time Volume Trigger Notifications - newser.com
November 2025's Leading Growth Companies With High Insider Ownership - simplywall.st
Will Precigen Inc. benefit from macro trendsDay Trade & Capital Protection Trade Alerts - newser.com
Precigen Inc (PGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Precigen Inc 주식 (PGEN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| KINDLER JEFFREY B | Director |
Sep 29 '25 |
Sale |
3.60 |
67,523 |
243,083 |
452,907 |
| KIRK RANDAL J | Director |
Sep 30 '25 |
Sale |
3.41 |
1,809,667 |
6,170,964 |
14,597,161 |
1.43%
0.07%
자본화:
|
볼륨(24시간):